
About Us
At Pinnacle Clinical Research, we’re advancing medicine by connecting groundbreaking science with the people who need it most. As a premier multi-site research network, we specialize in liver disease, brain, and cardiometabolic conditions — delivering industry-leading performance for sponsors and life-changing opportunities for patients. Our expert investigators, diverse populations, and patient-first approach make us a trusted partner and resource in clinical trials in the communities we serve.
Why Choose PCR
At Pinnacle, we deliver results that matter. Sponsors choose us for our proven ability to launch trials quickly, enroll diverse and at-risk populations, and consistently exceed performance benchmarks. Patients trust us for access to cutting-edge treatments, personalized support, and a team that puts their health and dignity first. Whether advancing science or accessing care, Pinnacle is where meaningful research meets real impact.
Delivering Results Where Precision Matters
We bring deep experience in conducting complex trials, particularly in metabolic and liver-related diseases, cognitive decline, and other high-impact therapeutic areas. Our investigators and coordinators are trained in protocol adherence, endpoint integrity, and advanced diagnostic modalities—ensuring that even the most intricate protocols are executed with precision.
Fast, Reliable Recruitment Without Compromising Quality
We pride ourselves on rapid, high-quality patient enrollment driven by our robust database, multilingual outreach teams, and community engagement strategies. With locations across Texas, New Jersey, California and Nevada, we ensure diverse representation in clinical trials—a growing regulatory and scientific imperative for generalizability and equity.
Streamlined Operations for Multi-Site Success
As part of a high-performing site network, Pinnacle offers Sponsors and CROs scalable access to multiple, centrally managed research sites. With harmonized SOPs, shared data platforms, and quality systems oversight, you gain the efficiency of a single point of contact without sacrificing local site performance.
Your Trusted Partner in Regulatory Readiness and Data Integrity
Our regulatory, QA, and data teams are embedded within the research lifecycle from feasibility to closeout. Pinnacle is known for audit-ready documentation, transparent communication, and clean data delivery. We take pride in being a dependable partner you can trust with your critical studies—on time, every time.
Critical Key Performance Indicators (KPIs)
At Pinnacle Clinical Research, performance is more than a promise — it’s a measurable standard. Pinnacle is the proven partner you can trust to execute with excellence, precision, and integrity.
Expedited Study Startup
Our streamlined internal processes, experienced regulatory team, and proactive communication allow us to consistently activate trials in under 30 days or faster as external engagements allow. We prioritize startup timelines to minimize delays and get trials enrolling faster.
TAT and 7-10 days Receipt to Execution
We operate with a centralized contract and finance team that manages a single budget and contract for all site locations. This allows us to rapidly review and execute agreements, eliminating redundant back-and-forth and ensuring predictable timelines allowing us to achieve a 48 hour turnaround time on initial response and 7-10 business days from receipt to execution.
from activation to first patient screened
Our active patient databases, pre-screening workflows, and engaged community relationships enable us to screen our first patient immediately, ideally the day after activation green light. Sponsors benefit from immediate momentum in enrollment.
Global enrollment for MASH studies
Our team has a proven track record in metabolic liver disease, regularly ranking among the top global enrollers for MASH trials. We combine targeted outreach, diverse patient populations, and clinical expertise to exceed enrollment goals.
Retention rate across Longitudinal trials
Patient retention is critical to study success. While retention rates are well known to be protocol dependent, our sites have a history of maintaining retention rates from 70% to 90%+ through culturally competent care, bilingual support, convenient scheduling, and strong patient engagement strategies throughout the trial lifecycle.
National Leaders
In Alzheimer’s and Dementia research
Our Alzheimer’s trials are led by nationally recognized Key Opinion Leaders in cognitive disorders — making Pinnacle a go-to site network for sponsors seeking expert oversight, scientific credibility, and accelerated trial success in AD and related dementias.
